© 1999 by European Society of Cardiology
Antiarrhythmic benefits of dual chamber stimulation with rate-response in patients with paroxysmal atrial fibrillation and chronotropic incompetence
A prospective, multicentre study










*Clinica Villa Tiberia Rome, Italy;
Fatebenefratelli Hospital Rome, Italy;
Civil Hospital Rome, Italy;
S. Camillo Hospital Rome, Italy;
||Policlinico S. Orsola Bologna, Italy;
¶Hospital S. Anna Como, Italy;
**Civil Hospital Brescia, Italy;

S. Agostino Hospital Modena, Italy;

Civil Hospital Gorizia, Italy;

Cannizzaro Hospital Catania, Italy;
||||University of Catania Catania, Italy
BACKGROUND: While the haemodynamic benefits of DDDR pacing compared with DDD pacing in patients with bradytachy syndrome and chronotropic incompetence (CI) are well demonstrated, the antiarrhythmic advantage is controversial and so far not clearly demonstrated.
AIM: We have performed a prospective, randomized, multicentre study to evaluate the efficacy of DDDR and DDD pacing modes in preventing paroxysmal atrial fibrillation (PAF) episodes in patients with bradytachy syndrome and CI.
METHODS AND RESULTS: Seventy-eight patients were included in the study. All patients had a dual chamber pacemaker implanted and were randomly programmed to DDD or DDDR with a cross over (DDD
DDDR or vice versa) at 3 months. The final evaluation was performed at 6 months by means of two self-administered symptom questionnaires to evaluate activity. Symptoms of palpitations were analysed and scored. The patients were less symptomatic with the DDDR mode. The number of mode-switch activations compared with symptomatic episodes of PAF confirmed the high rate of asymptomatic PAF episodes in patients with bradytachy syndrome. We conclude that in a small but well defined population of patients affected by sick sinus syndrome with CI and severely symptomatic PAF, DDDR pacing compared with DDD pacing may offer an additional antiarrhythmic benefit and should be considered the primary mode of pacing.
Key Words: Dual chamber rate responsive pacing, sick sinus syndrome, chronotropic incompetence, antiarrhythmic effect of pacing, paroxysmal atrial arrhythmias
Correspondence: Prof. Fulvio Bellocci MD, Policlinico Universitario A. Gemelli, Istituto di Cardiologia Largo Agostino Gemelli, 8, 00168 Roma, Italy.
[1] Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PE. Prospective randomized trial versus ventricular pacing in sick syndrome. Lancet 1994; 344: 15231528.[CrossRef][Web of Science][Medline]
[2] Andersen HR, Nielsen JC, Thomsen PE. Long term follow-up patients from a randomised trial of atrial versus ventrucular pacing for sick sinus syndrome. Lancet 1997; 350: 12101216.[CrossRef][Web of Science][Medline]
[3] Pollack A and Rodney HF. Pacemaker therapy in patients with atrial fibrillation. Am Heart J 1993; 125: 824830.[CrossRef][Web of Science][Medline]
[4] Connolly SJ, Kerr C, Gent M, Yusuf S. Dual chamber versus ventricular pacing. Critical appraisal of current data. Circulation 1996; 94: 57883.
[5] Kamalvand K, Tan K, Kotsakis A, Bucknall C, Sulke N. Is mode switching beneficial? A randomised study in patients with paroxysmal tachyarrhythmias. J Am Coll Card 1997; 30: 496504.[Abstract]
[6] Sutton R. DDD R pacing. PACE 1990; 13: 385387.
[7] Barold SS and Sanders R. Rate-adaptive cardiac pacing: cost versus technology versus patient benefit. Am Heart J 1993; 126: 18281834.[CrossRef]
[8] Hatano K, Kato R, Hayashy H. Usefulness of RR atrial pacing in patients with sick sinus syndrome. PACE 1989; 12: 1624.
[9] Spencer W, Markowitz T, Alagama P. Rate Augmentation and atrial arrhythmias in DDDR pacing. PACE 1990; 13: 18471851.
[10] Mond HG and Barold SS. Dual chamber rate-adaptive pacing in patients with paroxysmal supraventricular arrhythmias. PACE 1993; 16: 21682185.
[11] Heywood GA, Katritsis D, Ward J. Atrial adaptive rate pacing in sick sinus syndrome: effects on exercise capacity and arrhythmias. Br Heart J 1993; 69: 174178.
[12] Medtronic Thera Series Manual. Minneapolis MN, U S A Medtronic Inc.
[13] Attuel P, Pellerin D, Mugica J, Coumel P. DDD pacing: an effective treatment modality for recurrent atrial arrhythmias. PACE 1988; 11: 16471654.
[14] Keane D, Zon L, Ruskin J. Non pharmacologic therapies for atrial fibrillation. Am J Cardiol 1998; 81: 41C45C.[CrossRef][Web of Science][Medline]
[15] Papageorgiu P, Anselme F, Kirchoff CJ. Coronary sinus pacing prevents induction of atrial fibrillation. Circulation 1997; 961: 18931898.
[16] Padeletti L, Porciani MC, Michelucci A. Interatrial septum pacing a new system to pace simultaneously both atria on patients with paroxysmal atrial fibrillation. G Ital Cardiol 1998; 28: 49.
[17] Saksena S, Prakash A, Hill M. Prevention of recurrent atrial fibrillation with chronic dual site right atrial pacing. J Am Coll Cardiol 1996; 28: 687694.[Abstract]
[18] Daubert JC, Gras D, Leclerq C, Boisset JM, Victor F, Mabo P. Biatrial synchronous pacing: a new therapeutic approach to prevent refractory atrial arrhythmias (Abstr). J Am Coll Cardiol 1995; 25: 230A.
[19] Johnston FA, Robinson JF, Fyfe T. Exercise testing in the diagnosis of sick sinus syndrome in the elderly. PACE 1987; 10: 831838.
[20] Wilkoff BL, Corey J, Blackburn G. A mathematical model of cardiac chronotherapeutic response to exercise. J Electrocardiogr 1989; 3: 176180.
[21] Rosenquist M, Ahen C, Kristenson BE. Atrial rate responsive pacing in sinus node disease. Eur Heart J 1990; 11: 537542.
[22] Ricci R, Puglisi A, Azzolini P. Reliability of a new algorithm for automatic mode switching from DDDR to DDI-R pacing mode in sinus node disease patients with chronotrophic incompetence and recurrent PAF. PACE 1996; 19: 17191723.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. W. Israel Studying atrial fibrillation: what can we learn from the AFTherapy study? Europace, December 1, 2007; 9(12): 1107 - 1109. [Full Text] [PDF] |
||||
![]() |
A.J. Camm, N. Sulke, N. Edvardsson, P. Ritter, B.A. Albers, J.H. Ruiter, T. Lewalter, P.A. Capucci, E. Hoffmann, and on behalf of the AFTherapy investigators Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study Europace, December 1, 2007; 9(12): 1110 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bakhtiary, O. Dzemali, C. K. Bastanier, A. Moritz, and P. Kleine Medium-term follow-up and modes of failure following epicardial pacemaker implantation in young children Europace, February 1, 2007; 9(2): 94 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Anand, B. W. McCrindle, C. C. Chiu, R. M. Hamilton, J. A. Kirsh, E. A. Stephenson, and G. J. Gross Chronotropic incompetence in young patients with late postoperative atrial flutter: a case-control study Eur. Heart J., September 1, 2006; 27(17): 2069 - 2073. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Puglisi, G. Altamura, F. Capestro, B. Castaldi, G. Critelli, S. Favale, L. Pavia, and G. Pettinati Impact of Closed-Loop Stimulation, overdrive pacing, DDDR pacing mode on atrial tachyarrhythmia burden in Brady-Tachy Syndrome: A randomized study Eur. Heart J., November 1, 2003; 24(21): 1952 - 1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ricci, C. Pignalberi, M. Disertori, A. Capucci, L. Padeletti, G. Botto, S. Toscano, F. Miraglia, A. Grammatico, and M. Santini Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias Eur. Heart J., September 2, 2002; 23(18): 1471 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Manolis, A. G. Katsivas, C. Vassilopoulos, D. Koutsogeorgis, and N. E. Louvros Prevention of atrial fibrillation by inter-atrial septum pacing guided by electrophysiological testing, in patients with delayed interatrial conduction Europace, January 1, 2002; 4(2): 165 - 174. [Full Text] [PDF] |
||||
![]() |
G. Boriani, M. Biffi, L. Padeletti, A. Sparnpinato, G. Luca Botto, C. Pignalberi, A. Grammatico, D.A. Hettrick, F. De Seta, and A. Branzi Effects of consistent atrial pacing and atrial rate stabilization - two pacing algorithms to suppress recurrent paroxysmal atrial fibrillation in brady-tachy syndrome Eur. Heart J. Suppl., November 1, 2001; 3(suppl_P): P7 - P15. [Abstract] [PDF] |
||||
![]() |
M Santini and R Ricci Atrial fibrillation coexisting with ventricular tachycardia: a challenge for dual chamber defibrillators Heart, September 1, 2001; 86(3): 253 - 254. [Full Text] [PDF] |
||||
![]() |
J. Lass, J. Kaik, K. Meigas, H. Hinrikus, and A. Blinowska Evaluation of the quality of rate adaptation algorithms for cardiac pacing Europace, January 1, 2001; 3(3): 221 - 228. [Abstract] [PDF] |
||||
![]() |
R. SUTTON Is rate response superior to single rate pacing in atrial arrhythmia control? Europace, January 1, 1999; 1(4): 211 - 212. [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



